Blog Introduction
If you've spent any time searching peptide literature, you've probably noticed that CJC-1295 and Ipamorelin almost never show up alone. They show up together — in forum threads, in supplier catalogs, in the methods sections of preclinical papers. That's not a marketing coincidence. It comes down to how these two research compounds interact with the growth hormone axis, and why combining a GHRH analog with a selective GHRP has become one of the most studied pairings in growth-hormone secretagogue research.
Featured Product
This guide breaks down what CJC-1295 and Ipamorelin actually are, why researchers pair them, what the published literature says about the combination, and — just as important — what to look for in a research-grade blend before you order one. We'll cover purity testing, Certificates of Analysis (COAs), storage considerations, and how a CJC-1295 + Ipamorelin blend compares to sourcing each peptide separately.
Compliance note: CJC-1295 and Ipamorelin are sold by 99 Purity Peptides strictly as research chemicals for laboratory and in-vitro research use. They are not approved by the FDA for human use, and nothing in this article should be read as medical, dosing, or self-administration guidance.
What Is CJC-1295?
CJC-1295 is a synthetic analog of growth hormone-releasing hormone (GHRH), more specifically a modified version of GRF 1-29 (the first 29 amino acids of natural GHRH, which retain full biological activity in laboratory models). In research literature, CJC-1295 is studied for its ability to stimulate the pituitary gland's release of growth hormone in a pulsatile, GHRH-receptor-mediated manner.
There are two commonly referenced variants in the research space:
- CJC-1295 with DAC (Drug Affinity Complex) — a modification that binds to albumin in circulation, extending the compound's half-life in research models to several days.
- CJC-1295 no DAC (also called Modified GRF 1-29) — the unmodified fragment, with a much shorter half-life, more closely mirroring the pulsatile release pattern of endogenous GHRH.
Most blended vials — including the one supplied by 99 Purity Peptides — use CJC-1295 no DAC, because its shorter half-life is considered a better match for pairing with a fast-acting GHRP like Ipamorelin in pulsatile-release research designs.
What Is Ipamorelin?
Ipamorelin is a pentapeptide classified as a growth hormone-releasing peptide (GHRP) and a ghrelin receptor agonist. What sets Ipamorelin apart from earlier-generation GHRPs (like GHRP-6 or GHRP-2) is its selectivity: research literature consistently describes Ipamorelin as producing a more targeted growth-hormone-release signal, with minimal reported impact on cortisol and prolactin in study models — a distinguishing trait researchers frequently cite when choosing it over older secretagogues.
Because Ipamorelin and GHRH analogs act on different receptor pathways — ghrelin receptor versus GHRH receptor — combining the two is a recognized strategy in secretagogue research for producing a more robust GH-release signal than either compound alone.
Why Are CJC-1295 and Ipamorelin Studied Together?
Quick answer: CJC-1295 (a GHRH analog) and Ipamorelin (a selective GHRP) act on two separate receptor pathways that both converge on pituitary growth hormone release. Researchers combine them to study synergistic — rather than purely additive — GH-release signaling.
This GHRH-plus-GHRP research rationale isn't unique to this pairing; it's a well-established framework in growth hormone secretagogue science generally. What makes CJC-1295 + Ipamorelin one of the more frequently referenced combinations is the compatibility between CJC-1295 no DAC's short half-life and Ipamorelin's rapid, selective action, which allows researchers to model pulsatile GH release patterns that more closely resemble natural physiology.
Key Mechanistic Points
- CJC-1295 binds the GHRH receptor on somatotroph cells in the pituitary.
- Ipamorelin binds the ghrelin receptor (GHS-R1a), a distinct signaling pathway.
- Dual-pathway stimulation is the basis for the "synergistic peptide combination" framing used throughout the research literature.
- Ipamorelin's receptor selectivity is the reason it's frequently chosen over GHRP-6 or GHRP-2 in combination studies.
CJC-1295 + Ipamorelin vs. Other GHRH/GHRP Combinations
Researchers comparing secretagogue combinations often want to see how CJC-1295 + Ipamorelin stacks up against similar pairings, such as Sermorelin + Ipamorelin or Tesamorelin + Ipamorelin. The table below summarizes the research-relevant chemical distinctions — not a comparison of effects in humans.
Compound Class | Representative Peptide | Receptor Target | Half-Life Category (Research Models) |
|---|---|---|---|
GHRH analog (fragment) | CJC-1295 no DAC | GHRH receptor | Short |
GHRH analog (extended) | CJC-1295 with DAC | GHRH receptor | Extended (albumin-bound) |
GHRH analog (fragment) | Sermorelin | GHRH receptor | Very short |
GHRH analog (fusion protein) | Tesamorelin | GHRH receptor | Short |
Selective GHRP | Ipamorelin | Ghrelin receptor (GHS-R1a) | Short |
Non-selective GHRP | GHRP-6 | Ghrelin receptor (GHS-R1a) | Short |
This is a chemistry-and-pharmacokinetics comparison intended for research context — it is not a recommendation regarding suitability for any particular study design or use case.
Purity, Third-Party Testing, and Certificates of Analysis (COA)
Peptide purity is arguably the single most important variable in reproducible research results. Contaminated or degraded peptide stock can invalidate an entire study, which is why purity verification deserves more attention than price when comparing suppliers.
What a Legitimate COA Should Include
- Purity percentage, verified by High-Performance Liquid Chromatography (HPLC).
- Molecular weight confirmation, typically cross-checked with mass spectrometry.
- Batch or lot number matching the vial received.
- Testing lab name — ideally an independent, third-party laboratory rather than an in-house test.
- Date of analysis.
Checklist: Before ordering any CJC-1295 + Ipamorelin blend, confirm the supplier can provide a batch-matched COA, HPLC purity data, and third-party (not self-reported) lab verification.
99 Purity Peptides publishes a Certificate of Analysis for every batch of its CJC-1295 + Ipamorelin blend, generated via independent HPLC and mass spectrometry testing, so researchers can verify purity and molecular identity before use.
Blended Vial vs. Individually Purchased Peptides
A common question in the research community is whether a pre-mixed CJC-1295 + Ipamorelin blend offers any advantage over sourcing each peptide in a separate vial. Both approaches appear throughout the literature, and the right choice depends on the study design.
Factor | Pre-Mixed Blend | Individual Vials |
|---|---|---|
Preparation steps | Single reconstitution step | Two separate reconstitution steps |
Ratio consistency | Fixed by manufacturer | Fully adjustable by researcher |
COA scope | One COA covers the combined vial | Separate COA per peptide |
Best suited for | Standardized, repeatable protocols | Studies requiring independent dosing control |
Neither format is inherently superior — it's a question of matching the vial format to the study's methodology and the level of independent control the protocol requires over each peptide.
Storage and Stability Considerations
Lyophilized (freeze-dried) CJC-1295 + Ipamorelin blends are generally more stable than reconstituted solutions and should be kept frozen or refrigerated according to the supplier's storage guidance, protected from light and repeated temperature cycling. Once reconstituted, peptide solutions are considerably more sensitive to temperature and time, which is why suppliers typically recommend refrigeration and use within a defined window rather than long-term storage in liquid form.
Key takeaway: Lyophilized peptide is stable for extended storage; once reconstituted for laboratory use, stability drops significantly, so researchers should follow the supplier's specific storage documentation included with each batch.
Is CJC-1295 + Ipamorelin Legal to Purchase in the USA?
CJC-1295 and Ipamorelin are sold in the United States as research chemicals, labeled "for laboratory research use only, not for human consumption." This is a standard classification for peptides that have not completed FDA approval for human therapeutic use. Reputable suppliers, including 99 Purity Peptides, restrict sales to research and laboratory contexts and require that products not be represented, marketed, or used as drugs, supplements, or cosmetics.
Choosing a Research-Grade CJC-1295 + Ipamorelin Supplier
With so many peptide vendors competing for the same search terms, it helps to have a short, objective checklist rather than relying on price alone.
- Independent, third-party COA for every batch (not just an internal spec sheet).
- HPLC and mass spectrometry data disclosed, not just a purity percentage claim.
- Clear "research use only" labeling and compliance language on the product page.
- USA-based sourcing and domestic shipping, which typically means shorter transit times and easier customer support.
- Transparent vial sizing (5mg, 10mg, etc.) with molecular weight and CAS numbers listed.
- Responsive customer service for compliance and documentation questions.
Key Takeaways
- CJC-1295 is a GHRH analog; Ipamorelin is a selective GHRP — they act on two different receptor pathways (GHRH receptor vs. ghrelin receptor).
- Researchers combine them to study dual-pathway, synergistic growth hormone release signaling rather than a single-pathway effect.
- CJC-1295 no DAC (short half-life) is the variant most commonly paired with Ipamorelin in blended vials.
- Purity verification — HPLC data, third-party testing, and a batch-matched COA — matters more than price when evaluating suppliers.
- Blended vials simplify preparation for standardized protocols; individual vials give more independent control over each peptide.
- CJC-1295 and Ipamorelin are sold in the USA strictly as research-use-only chemicals, not for human consumption.
Frequently Asked Questions
What is the difference between CJC-1295 and Ipamorelin?
CJC-1295 is a GHRH analog that acts on the GHRH receptor, while Ipamorelin is a selective GHRP that acts on the ghrelin receptor. They stimulate growth hormone release through two distinct pathways.
Why are CJC-1295 and Ipamorelin often researched together?
Because they act on different receptors that both converge on pituitary GH release, researchers study the combination for potential synergistic, dual-pathway signaling.
What does a CJC-1295 + Ipamorelin blend contain?
A blended vial typically contains lyophilized CJC-1295 (usually the no-DAC variant) and Ipamorelin in a fixed ratio determined by the manufacturer.
Is CJC-1295 no DAC or with DAC used in the blend?
Most research blends use CJC-1295 no DAC because its shorter half-life is considered a closer match to Ipamorelin's rapid, pulsatile action.
How should a CJC-1295 + Ipamorelin blend be stored?
Lyophilized peptide should be kept frozen or refrigerated, protected from light, per the supplier's storage documentation; once reconstituted, stability decreases and refrigeration with prompt use is recommended.
Is a CJC-1295 + Ipamorelin blend more stable than individual vials?
Stability is primarily determined by lyophilization and storage conditions rather than by whether the peptides are combined, so blended and individual vials follow similar stability principles.
What is the molecular formula of Ipamorelin?
Ipamorelin is a pentapeptide with a well-documented molecular formula and CAS number, which should be listed on the supplier's Certificate of Analysis and product specification sheet.
Where does 99 Purity Peptides source its CJC-1295 and Ipamorelin?
99 Purity Peptides sources its research peptides from USA-based manufacturing partners and verifies each batch through independent third-party laboratory testing.
Does 99 Purity Peptides provide a Certificate of Analysis for blends?
Yes. Every batch is shipped with a batch-matched Certificate of Analysis showing HPLC purity data and mass spectrometry confirmation.
How is CJC-1295 + Ipamorelin blend purity verified?
Purity is verified using High-Performance Liquid Chromatography (HPLC) and mass spectrometry, ideally performed by an independent third-party laboratory rather than in-house.
Is CJC-1295 + Ipamorelin blend sold as research-use-only?
Yes. It is sold strictly for laboratory and research use and is not approved by the FDA for human consumption or therapeutic use.
What sizes/vial amounts does the CJC-1295 + Ipamorelin blend come in?
Common research vial sizes include 5mg and 10mg combined blends, though exact options vary by supplier and batch availability.
Why might a researcher choose a blend over buying CJC-1295 and Ipamorelin separately?
A blend simplifies protocol preparation with a single reconstitution step and fixed ratio, which can support standardized, repeatable research designs.
What is the CAS number for CJC-1295 and Ipamorelin?
Both peptides have distinct, publicly documented CAS numbers that should appear on the supplier's specification sheet and Certificate of Analysis.
What published research exists on CJC-1295 and Ipamorelin combinations?
Growth hormone secretagogue research, including studies on GHRH analogs and selective GHRPs, is documented in peer-reviewed literature available through databases such as PubMed.
